Drug Modeling Software Market Forecasts to 2028 – Global Analysis By Deployment (On-Premise, Cloud-Based), End User (Research Institutes, Laboratory, Educational Institutes) and By Geography
According to Stratistics MRC, the Global Drug Modeling Software Market is accounted for $6,707.84 million in 2020 and is expected to reach $14,483.76 million by 2028 growing at a CAGR of 10.1% during the forecast period. Factors such as increasing prevalence of various lifestyle diseases, advancement of information technology, and rising expenditure on healthcare are driving the growth of the market. However, stringent regulations associated with the development and testing of drugs are hampering the growth of the market.
Drug modeling software is used to develop new pharmaceutical drugs and test whether it is effective in treating a particular disease. It is an essential tool in the drug design process as it provides insights of experimental findings and mechanisms of action.
Based on the application, the drug discovery and development segment is anticipated to expand at a rapid pace during the forecast period owing to the need for better therapeutic agents for different diseases. By geography, North America is going to have high growth during the forecast period which can be attributed to the availability of high end technologies and modern infrastructure which helps in carrying out drug modeling effectively.
Some of the key players profiled in the Drug Modeling Software Market include Schrodinger, Inc., Biognos Ab, Crown Bioscience Inc, Acellera Ltd, Dassault Systemes , Chemical Computing Group Ulc, Genedata Ag , Nimbus Therapeutics, Leadscope Inc, and Compugen Ltd.
Estimated Market Size in 2020:
USD 6,707.84 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 14,483.76 million
Tables, Graphs & Figures
Deployment, Product, Application, End User, and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Drug Discovery and Development
• Simulation Software
• Disease Modeling
• Predictive Analysis of Drug Targets
• Computational Physiological Medicine
• Cellular Simulation
• Medical Imaging
End Users Covered:
• Research Institutes
• Educational Institutes
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Drug Modeling Software Market is majorly driven by the increasing prevalence of various lifestyle diseases, advancement of information technology, and rising expenditure on healthcare.
The software segment is growing at a highest CAGR as it offers cost-effective drug discovery and designing methods thereby helping the expansion of new bio-active drugs.
North America dominated with a significant market share due to the factors such as the availability of high end technologies and presence of modern infrastructure in the region.
Asia Pacific market is growing at a highest CAGR owing to the increasing geriatric population and growing awareness regarding the benefits of therapeutic drugs.
Key players in Drug Modeling Software Market include Schrodinger, Inc., Biognos Ab, Crown Bioscience Inc, Acellera Ltd, Dassault Systemes , Chemical Computing Group Ulc, Genedata Ag , Nimbus Therapeutics, Leadscope Inc, and Compugen Ltd.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.